Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision Without Change of a Previously Approved Collection Recordkeeping for Electronic Prescriptions for Controlled Substances, 93348-93349 [2024-27683]
Download as PDF
93348
Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices
The company plans to bulk
manufacture the listed controlled
substances to be used in analytical
testing. In reference to drug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–27693 Filed 11–25–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0049]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision
Without Change of a Previously
Approved Collection Recordkeeping
for Electronic Prescriptions for
Controlled Substances
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
January 27, 2025.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Heather E. Achbach, Regulatory Drafting
and Policy Support Section, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 776–3882; Email:
SUMMARY:
Heather.E.Achbach@dea.gov or
DEA.PRA@dea.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection.
2. Title of the Form/Collection:
Recordkeeping for Electronic
Prescriptions for Controlled Substances.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
No form number is associated with this
collection. The applicable component
within the Department of Justice is the
Drug Enforcement Administration,
Diversion Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: DEA is requiring that each
registered practitioner apply to an
approved credential service provider
approved to obtain identity proofing
and a credential. Hospitals and other
institutional practitioners may conduct
this process in-house as part of their
credentialing. For practitioners
currently working at or affiliated with a
registered hospital or clinic, the
hospital/clinic have to check a
government-issued photographic
identification. This may be done when
the hospital/clinic issues credentials to
new hires or newly affiliated
physicians. For individual practitioners,
two people need to enter logical access
control data to grant permissions for
practitioners authorized to approve and
sign controlled substance prescriptions
using the electronic prescription
application. For institutional
practitioners, logical access control data
is entered by two people from an entity
within the hospital/clinic that is
separate from the entity that conduct
identity proofing in-house. Similarly,
pharmacies have to set logical access
controls in the pharmacy application so
that only authorized employees have
permission to annotate or alter
prescription records. Finally, if the
electronic prescription or pharmacy
application generates an incident report,
practitioners, hospitals/clinics, and
pharmacies have to review the incident
report to determine if the event
identified by the application represents
a security incident.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that
158,884 registrants participate in this
information collection, taking an
estimated 40 minutes for Practitioner,
128 minutes for Hospital/Clinic, and 20
minutes for Pharmacy.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates that
this collection takes 107,733 annual
burden hours.
7. An estimate of the total annual cost
burden associated with the collection, if
applicable: $0.
lotter on DSK11XQN23PROD with NOTICES1
TOTAL BURDEN HOURS
Number of
respondents
Activity
Frequency
Total annual
responses
Time per response
Total annual
burden
(hours)
Practitioner .........................................................................
Hospital/Clinic ....................................................................
Pharmacy ...........................................................................
154,571
1,526
2,787
1
1
1
154,571
1,526
2,787
0.67 (40 minutes) ...
2.13 (128 minutes)
0.33 (20 minutes) ...
103,563
1,526
2,787
Unduplicated Totals ....................................................
158,884
N/A
158,884
1.043 ......................
107,733
VerDate Sep<11>2014
18:03 Nov 25, 2024
Jkt 265001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
E:\FR\FM\26NON1.SGM
26NON1
Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices
If additional information is required
contact: Darwin Arceo, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 4W–218,
Washington, DC.
Dated: November 21, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2024–27683 Filed 11–25–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0339]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection;
Comments Requested: Generic
Clearance for Cognitive, Pilot and Field
Studies for Bureau of Justice Statistics
Data Collection Activities
Bureau of Justice Statistics,
Department of Justice
ACTION: 30-Day notice.
AGENCY:
The Bureau of Justice
Statistics (BJS), Department of Justice
(DOJ) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 26, 2024.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Devon Adams, Bureau of Justice
Statistics, 999 N Capitol St. NE,
Washington, DC 20531 (email:
Devon.Adams@usdoj.gov; telephone:
202–307–0765).
SUPPLEMENTARY INFORMATION: The
proposed information collection was
previously published in the Federal
Register, volume 89 pages 77545–6, on
September 23, 2024. No comments were
received.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:03 Nov 25, 2024
Jkt 265001
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number [1121–0240]. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Abstract: Over the next three years,
BJS anticipates undertaking a variety of
new surveys and data collections, as
well as reassessing ongoing statistical
projects, across a number of areas of
criminal justice, including law
enforcement, courts, corrections, and
victimization. This work will entail
development of new survey
instruments, redesigning and/or
modifying existing surveys, procuring
administrative data from state and local
government entities, and creating or
modifying establishment surveys. In
order to inform BJS data collection
protocols, to develop accurate estimates
of respondent burden, and to minimize
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
93349
respondent burden associated with each
new or modified data collection, BJS
will engage in cognitive, pilot and field
test activities to refine instrumentation
and data collection methodologies. BJS
envisions using a variety of techniques,
including but not limited to tests of
different types of survey and data
collection operations, sample frame
development, focus groups, cognitive
testing, pilot testing, exploratory
interviews, experiments with
questionnaire design, and usability
testing of electronic data collection
instruments.
Following standard Office of
Management and Budget (OMB)
requirements, BJS will submit a change
request to OMB individually for every
group of data collection activities
undertaken under this generic
clearance. BJS will provide OMB with a
copy of the individual instruments or
questionnaires (if one is used), as well
as other materials describing the project.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. The Title of the Form/Collection:
Generic Clearance for cognitive, pilot
and field studies for Bureau of Justice
Statistics data collection Activities.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form numbers not available for generic
clearance. The applicable component
within the Department of Justice is the
Bureau of Justice Statistics, in the Office
of Justice Programs.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Administrators or staff of state
and local agencies or programs in the
relevant fields; administrators or staff of
non-government agencies or programs
in the relevant fields; individuals;
policymakers at various levels of
government.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: We estimate that
approximately 30,000 respondents will
be involved in exploratory, field test,
pilot, cognitive, and focus group work
conducted under this clearance over the
requested 3-year clearance period. The
average response time per respondent
will be specific to each project covered
under the clearance. Specific estimates
of the number of respondents and the
average response time are not known for
each pilot study or development project
covered under a generic clearance at
this time. Project specific estimates will
E:\FR\FM\26NON1.SGM
26NON1
Agencies
[Federal Register Volume 89, Number 228 (Tuesday, November 26, 2024)]
[Notices]
[Pages 93348-93349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27683]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0049]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Revision Without Change of a Previously Approved
Collection Recordkeeping for Electronic Prescriptions for Controlled
Substances
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
January 27, 2025.
FOR FURTHER INFORMATION CONTACT: If you have additional comments
especially on the estimated public burden or associated response time,
suggestions, or need a copy of the proposed information collection
instrument with instructions or additional information, please contact
Heather E. Achbach, Regulatory Drafting and Policy Support Section,
Drug Enforcement Administration; Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
[email protected] or [email protected].
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the Bureau of Justice
Statistics, including whether the information will have practical
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. Title of the Form/Collection: Recordkeeping for Electronic
Prescriptions for Controlled Substances.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: No form number is associated
with this collection. The applicable component within the Department of
Justice is the Drug Enforcement Administration, Diversion Control
Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: DEA is requiring that each registered practitioner apply
to an approved credential service provider approved to obtain identity
proofing and a credential. Hospitals and other institutional
practitioners may conduct this process in-house as part of their
credentialing. For practitioners currently working at or affiliated
with a registered hospital or clinic, the hospital/clinic have to check
a government-issued photographic identification. This may be done when
the hospital/clinic issues credentials to new hires or newly affiliated
physicians. For individual practitioners, two people need to enter
logical access control data to grant permissions for practitioners
authorized to approve and sign controlled substance prescriptions using
the electronic prescription application. For institutional
practitioners, logical access control data is entered by two people
from an entity within the hospital/clinic that is separate from the
entity that conduct identity proofing in-house. Similarly, pharmacies
have to set logical access controls in the pharmacy application so that
only authorized employees have permission to annotate or alter
prescription records. Finally, if the electronic prescription or
pharmacy application generates an incident report, practitioners,
hospitals/clinics, and pharmacies have to review the incident report to
determine if the event identified by the application represents a
security incident.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 158,884 registrants participate in this information collection,
taking an estimated 40 minutes for Practitioner, 128 minutes for
Hospital/Clinic, and 20 minutes for Pharmacy.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates that this collection takes
107,733 annual burden hours.
7. An estimate of the total annual cost burden associated with the
collection, if applicable: $0.
Total Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total annual
Activity Number of Frequency Total annual Time per response burden
respondents responses (hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Practitioner.................................... 154,571 1 154,571 0.67 (40 minutes).......................... 103,563
Hospital/Clinic................................. 1,526 1 1,526 2.13 (128 minutes)......................... 1,526
Pharmacy........................................ 2,787 1 2,787 0.33 (20 minutes).......................... 2,787
-------------------------------------------------------------------------------------------------------
Unduplicated Totals......................... 158,884 N/A 158,884 1.043...................................... 107,733
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 93349]]
If additional information is required contact: Darwin Arceo,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, 4W-218, Washington, DC.
Dated: November 21, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-27683 Filed 11-25-24; 8:45 am]
BILLING CODE 4410-09-P